Guest
Dr Robert Byrne (Mater Private Hospital, Dublin, IE) joins us on-site to discuss the new guidelines from the ESC covering the management of acute coronary syndromes. Acute Coronary Syndrome (ACS) is a broad spectrum of conditions, and the presentation can vary from a stable patient, to a patient who is critically ill. In the past, separate guidelines were issued for ST-Elevation Myocardial Infarction (STEMI) and Non-ST Elevation Myocardial Infarction (NSTEMI). The new ESC guidelines for ACS cover both NSTEMI and STEMI. The combined guidelines outlined a common pathway for the treatment of all patients diagnosed with ACS, including early invasive strategies, antithrombotic treatment strategies, revascularization and a focus on secondary prevention. NSTE-ACS early invasive treatment has also been downgraded to a class IIa recommendation from a class I. Questions: -What are the unmet needs of ACS patients in 2023? -What is new in the guidelines? -Is there any area that needs more attention? -What are some of the challenges and opportunities with the implementation of these recommendations? Recorded on-site at ESC Congress 2023, Amsterdam. Visit Radcliffe Cardiology: This content is intended for healthcare professionals only. Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster. Like us on Facebook: Follow us on Twitter:
